GIRAO TIAGO (Chief Financial Officer) sold 3.9% of their position (10K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $384.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/26/2026ACC: 0001764013-26-000072
Officer· Chief Financial Officer
Since Apr 2025
-10K
Net shares
Net seller
$384.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$15.90
Trade value
$159K
% of position
4.0%
6/26/2026
247.60K→257.60K
Common Stock
Direct
Shares
−10K
Price / share
$38.46
Trade value
$384.60K
% of position
3.9%
6/26/2026
257.60K→247.60K
Total
Net shares
+0.00
Net value
-$225.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/26/2026 | M · Option Exercise | +10K | $15.90 | $159K | 4.0% | 247.60K | 257.60K |
| Common Stock Direct | 6/26/2026 | S · Sale | −10K | $38.46 | $384.60K | 3.9% | 257.60K | 247.60K |
| Total | +0.00 | -$225.60K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
15.90
Held after
283.50K
Exercisable
—
6/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock10K shares | 6/26/2026 | M · Option Exercise | −10K | 15.90 | — | 283.50K |